Tech Company Financing Transactions
OncoPep Funding Round
OncoPep, operating out of Andover, secured $6.9 million in funding from The Leukemia & Lymphoma Society and private investors.
Transaction Overview
Company Name
Announced On
8/28/2014
Transaction Type
Venture Equity
Amount
$6,900,000
Round
Series B
Investors
The Leukemia & Lymphoma Society (Lee Greenberger)
Proceeds Purpose
Proceeds raised will support the clinical development of PVX-410, currently being studied in patients with smoldering multiple myeloma (SMM), an asymptomatic stage of MM.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
520 Boston St. North
Andover, MA 01845
USA
Andover, MA 01845
USA
Phone
Website
Email Address
Overview
OncoPep, Inc. was founded in 2010 to commercialize a novel approach to developing targeted immunotherapeutics against cancer. The Company's proprietary core technology was developed in the laboratory of Dr. Kenneth Anderson, M.D., a world leader in cancer treatment, at the Dana Farber Cancer Institute.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Marc Cohen
Chief Executive Officer
Doris Peterkin
Browse more venture capital transactions:
Prev: 8/28/2014: DreamFunded venture capital transaction
Next: 8/28/2014: Airspan Networks venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs